Literature DB >> 26300682

Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer for guiding chemotherapy in rare tumours?

V Kumar1, Y Xu2.   

Abstract

Sebaceous carcinoma is a rare malignant tumour of skin. It commonly occurs in the head and neck region. The standard of care for localized disease is wide local excision followed by radiotherapy. Occasionally, sebaceous carcinoma can be associated with Muir-Torre syndrome, which is characterized by sebaceous lesions and carcinomas in the visceral organs. Metastatic sebaceous carcinoma is even rarer, with very little evidence about the role of chemotherapy in the treatment of metastatic disease. Here, we report a case of recurrent sebaceous carcinoma metastatic to the rectum (initially mimicking rectal cancer and Muir-Torre syndrome) in which the disease responded to multiple lines of chemotherapy. We also review the available literature on chemotherapy in this disease and discuss the role of tumour profiling and genotype-guided selection of chemotherapeutics in such rare tumours.

Entities:  

Keywords:  Metastatic sebaceous carcinoma; Muir; Torre syndrome; genotyping; tumour profiles

Year:  2015        PMID: 26300682      PMCID: PMC4530829          DOI: 10.3747/co.22.2467

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  17 in total

1.  Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

Authors:  Daniel D Von Hoff; Joseph J Stephenson; Peter Rosen; David M Loesch; Mitesh J Borad; Stephen Anthony; Gayle Jameson; Susan Brown; Nina Cantafio; Donald A Richards; Tom R Fitch; Ernesto Wasserman; Cristian Fernandez; Sylvan Green; William Sutherland; Michael Bittner; Arlet Alarcon; David Mallery; Robert Penny
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

2.  Sebaceous carcinoma of the nose with a regional metastasis following false-negative sentinel lymph node biopsy.

Authors:  Shin-Ichi Osada; Takashi Ueno; Shunta Inai; Yayoi Niimi; Munenaga Nakamizo; Shin-Ichi Ansai; Seiji Kawana
Journal:  Acta Derm Venereol       Date:  2011-05       Impact factor: 4.437

3.  EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population.

Authors:  Cesare Gridelli; Antonio Rossi
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

4.  Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.

Authors:  J H Sinard
Journal:  Arch Ophthalmol       Date:  1999-06

Review 5.  Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.

Authors:  P R Cohen; S R Kohn; R Kurzrock
Journal:  Am J Med       Date:  1991-05       Impact factor: 4.965

6.  A retrospective review of 1349 cases of sebaceous carcinoma.

Authors:  Tina Dasgupta; Lynn D Wilson; James B Yu
Journal:  Cancer       Date:  2009-01-01       Impact factor: 6.860

7.  Sebaceous gland carcinoma. Review of 40 cases.

Authors:  M T Doxanas; W R Green
Journal:  Arch Ophthalmol       Date:  1984-02

8.  Palliative 5-fluorouracil and cisplatin chemotherapy in recurrent metastatic sebaceous carcinoma: Case report and literature review.

Authors:  Yun Hwa Jung; In Sook Woo; Min Young Kim; Chi Wha Han; Eun Young Rha
Journal:  Asia Pac J Clin Oncol       Date:  2013-08-27       Impact factor: 2.601

9.  Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells.

Authors:  Y Nakano; S Tanno; K Koizumi; T Nishikawa; K Nakamura; M Minoguchi; T Izawa; Y Mizukami; T Okumura; Y Kohgo
Journal:  Br J Cancer       Date:  2007-01-16       Impact factor: 7.640

10.  Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy.

Authors:  Angela Orcurto; Béatrice E Gay; Wendy Jeanneret Sozzi; Michel Gilliet; Serge Leyvraz
Journal:  Case Rep Dermatol       Date:  2014-03-13
View more
  6 in total

Review 1.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

Review 2.  Current Treatment Options for Cutaneous Adnexal Malignancies.

Authors:  Hiroyuki Goto
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

3.  Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma.

Authors:  Evidio Domingo-Musibay; Paari Murugan; Alessio Giubellino; Sandeep Sharma; Daniel Steinberger; Jianling Yuan; Matthew A Hunt; Emil Lou; Jeffrey S Miller
Journal:  J Immunother Cancer       Date:  2018-06-19       Impact factor: 13.751

4.  Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective.

Authors:  Marcin Kleibert; Iga Płachta; Anna M Czarnecka; Mateusz J Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

5.  Outcome after treatment for sebaceous carcinoma: A multicenter study.

Authors:  Eva Huis In 't Veld; Ronald Keizer; Nicoline Post; Jeroen Versteeg; Robert Verdijk; Nicole Naus; Germaine Relyveld; Marianne Crijns; Myles Smith; Dirk Grünhagen; Marlies Wakkee; Dion Paridaens; Ioannis Zavrakidis; Antien Mooyaart; Alexander van Akkooi; Dirk Strauss; Cornelis Verhoef; Michel Wouters; Andrew Hayes; Winan van Houdt
Journal:  J Surg Oncol       Date:  2022-01-06       Impact factor: 2.885

6.  A Case Report of Recurrent Metastatic Sebaceous Carcinoma Which Showed Favorable Response Tt Non-Fluorouracil Based Chemotherapy.

Authors:  Shin Hee Lee; Yun Hwa Jung; Ji Yeon Yoo; Hyo Jin Park
Journal:  Am J Case Rep       Date:  2018-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.